In Vivo Correlation of Tumor Blood Volume and Permeability with Histologic and Molecular Angiogenic Markers in Gliomas

References

1. 1.↵
   1. Folkman J

   . The role of angiogenesis in tumor growth. Semin Cancer Biol 1992;3:65–71

   PubMed
2. 2.↵
   1. Weidner N,
   2. Semple JP,
   3. Welch WR,
   4. et al

   . Tumor angiogenesis and metastasis: correlation in invasive breast carcinoma. N Engl J Med 1991;324:1–8

   CrossRefPubMedWeb of Science
3. 3.↵
   1. Weidner N

   . Tumoural vascularity as a prognostic factor in cancer patients: the evidence continues to grow. J Pathol 1998;184:119–22

   CrossRefPubMedWeb of Science
4. 4.↵
   1. Fox SB

   . Tumour angiogenesis and prognosis. Histopathology 1997;30:294–301

   CrossRefPubMedWeb of Science
5. 5.↵
   1. Tanaka F,
   2. Oyanagi H,
   3. Takenaka K,
   4. et al

   . Glomeruloid microvascular proliferation is superior to intratumoral microvessel density as a prognostic marker in non-small cell lung cancer. Cancer Res 2003;63:6791–94

   Abstract/FREE Full Text
6. 6.↵
   1. Wesseling P,
   2. Vandersteenhoven JJ,
   3. Downey BT,
   4. et al

   . Cellular components of microvascular proliferation in human glial and metastatic brain neoplasms: a light microscopic and immunohistochemical study of formalin-fixed, routinely processed material. Acta Neuropathol 1993;85:508–14

   PubMedWeb of Science
7. 7.↵
   1. Chaudhry IH,
   2. O'Donovan DG,
   3. Brenchley PE,
   4. et al

   . Vascular endothelial growth factor expression correlates with tumour grade and vascularity in gliomas. Histopathology 2001;39:409–15

   CrossRefPubMedWeb of Science
8. 8.↵
   1. Brat DJ,
   2. Van Meir EG

   . Glomeruloid microvascular proliferation orchestrated by VPF/VEGF: a new world of angiogenesis research. Am J Pathol 2001;158:789–96

   CrossRefPubMedWeb of Science
9. 9.↵
   1. Turetschek K,
   2. Preda A,
   3. Floyd E,
   4. et al

   . MRI monitoring of tumor response following angiogenesis inhibition in an experimental human breast cancer model. Eur J Nucl Med Mol Imaging 2003;30:448–55

   PubMed
10. 10.↵
    1. Aronen HJ,
    2. Gazit IE,
    3. Louis DN,
    4. et al

    . Cerebral blood volume maps of gliomas: comparison with tumor grade and histologic findings. Radiology 1994;191:41–51

    PubMedWeb of Science
11. 11.↵
    1. Griebel J,
    2. Mayr NA,
    3. de Vries A,
    4. et al

    . Assessment of tumor microcirculation: a new role of dynamic contrast MR imaging. J Magn Reson Imaging 1997;7:111–19

    PubMed
12. 12.↵
    1. Aronen HJ,
    2. Glass J,
    3. Pardo FS,
    4. et al

    . Echo-planar MR cerebral blood volume mapping of gliomas: clinical utility. Acta Radiol 1995;36:520–28

    PubMed
13. 13.↵
    1. Roberts HC,
    2. Roberts TP,
    3. Brasch RC,
    4. et al

    . Quantitative measurement of microvascular permeability in human brain tumors achieved using dynamic contrast-enhanced MR imaging: correlation with histologic grade. AJNR Am J Neuroradiol 2000;21:891–99

    Abstract/FREE Full Text
14. 14.↵
    1. Jackson A,
    2. Kassner A,
    3. Annesley-Williams D,
    4. et al

    . Abnormalities in the recirculation phase of contrast agent bolus passage in cerebral gliomas: comparison with relative blood volume and tumor grade. AJNR Am J Neuroradiol 2002;23:7–14

    Abstract/FREE Full Text
15. 15.↵
    1. Ellika SK,
    2. Jain R,
    3. Patel SC,
    4. et al

    . Role of perfusion CT in glioma grading and comparison with conventional MR imaging features. AJNR Am J Neuroradiol 2007;28:1981–87

    Abstract/FREE Full Text
16. 16.↵
    1. Jain R,
    2. Ellika SK,
    3. Scarpace L,
    4. et al

    . Quantitative estimation of permeability surface-area product in astroglial brain tumors using perfusion CT and correlation with histopathologic grade. AJNR Am J Neuroradiol 2008;29:694–700

    Abstract/FREE Full Text
17. 17.↵
    1. Weidner N

    . Current pathologic methods for measuring intratumoral microvessel density within breast carcinoma and other solid tumors. Breast Cancer Res Treat 1995;36:169–80

    CrossRefPubMedWeb of Science
18. 18.↵
    1. Kleihues P,
    2. Cavenee WK

    1. Giangaspero F,
    2. Bigner SH,
    3. Kleihues P,
    4. et al

    . Pathology and genetics of tumors of the nervous system. In: Kleihues P, Cavenee WK, eds. World Health Organization Classification of Tumours. Lyon, France: IARC; 2000:10–54
19. 19.↵
    1. Kleihues P,
    2. Burger PC,
    3. Scheithauer BW

    . The new WHO classification of brain tumors. Brain Pathol 1993;3:255–68

    CrossRefPubMedWeb of Science
20. 20.↵
    1. Leon SP,
    2. Folkerth RD,
    3. Black PM

    . Microvessel density is a prognostic indicator for patients with astroglial brain tumors. Cancer 1996;77:362–72

    CrossRefPubMedWeb of Science
21. 21.↵
    1. Assimakopoulou M,
    2. Sotiropoulou-Bonikou G,
    3. Maraziotis T,
    4. et al

    . Microvessel density in brain tumors. Anticancer Res 1997;17:4747–53

    PubMed
22. 22.↵
    1. Kleihues P,
    2. Soylemezoglu F,
    3. Schauble B,
    4. et al

    . Histopathology, classification, and grading of gliomas. Glia 1995;15:211–21

    CrossRefPubMedWeb of Science
23. 23.↵
    1. Weidner N

    . Intratumor microvessel density as a prognostic factor in cancer. Am J Pathol 1995;147:9–19

    PubMedWeb of Science
24. 24.↵
    1. Kleihues P,
    2. Cavenee WK

    1. Kleihues P,
    2. Burger PC,
    3. Plate KH,
    4. et al

    . Glioblastoma. In: Kleihues P, Cavenee WK, eds. Pathology and Genetics: Tumors of the Nervous System. 2nd ed. Lyon, France: IARC; 2000:88–89
25. 25.↵
    1. Ferrara N

    . Vascular endothelial growth factor: molecular and biological aspects. Curr Top Microbiol Immunol 1999;237:1–30

    PubMedWeb of Science
26. 26.↵
    1. Ferrara N,
    2. Davis-Smyth T

    . The biology of vascular endothelial growth factor. Endocr Rev 1997;18:4–25

    CrossRefPubMedWeb of Science
27. 27.↵
    1. Veikkola T,
    2. Alitalo K

    . VEGFs, receptors and angiogenesis. Semin Cancer Biol 1999;9:211–20

    CrossRefPubMedWeb of Science
28. 28.↵
    1. Dvorak HF,
    2. Brown LF,
    3. Detmar M,
    4. et al

    . Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 1995;146:1029–39

    PubMedWeb of Science
29. 29.↵
    1. Shweiki D,
    2. Neeman M,
    3. Itin A,
    4. et al

    . Induction of vascular endothelial growth factor expression by hypoxia and by glucose deficiency in multicell spheroids: implications for tumor angiogenesis. Proc Natl Acad Sci U S A 1995;92:768–72

    Abstract/FREE Full Text
30. 30.↵
    1. Jackson A

    . Imaging microvascular structure with contrast enhanced MRI. Br J Radiol 2003;76(spec no 2):S159–73

    FREE Full Text
31. 31.↵
    1. Risau W

    . Mechanisms of angiogenesis. Nature 1997;386:671–74

    CrossRefPubMedWeb of Science
32. 32.↵
    1. Bicknell RJ,
    2. Lewis CE,
    3. Ferrara N

    1. Bicknell RJ,
    2. Lewis CE,
    3. Ferrara N

    . The role of vascular endothelial growth factor in the regulation of blood vessel growth. In: Bicknell RJ, Lewis CE, Ferrara N, eds. Tumour Angiogenesis. Oxford, UK: Oxford University Press; 1997:185–99
33. 33.↵
    1. Law M,
    2. Yang S,
    3. Babb JS,
    4. et al

    . Comparison of cerebral blood volume and vascular permeability from dynamic susceptibility contrast-enhanced perfusion MR imaging with glioma grade. AJNR Am J Neuroradiol 2004;25:746–55

    Abstract/FREE Full Text
34. 34.↵
    1. Mills SJ,
    2. Patankar TA,
    3. Haroon HA,
    4. et al

    . Do cerebral blood volume and contrast transfer coefficient predict prognosis in human glioma? AJNR Am J Neuroradiol 2006;27:853–58

    Abstract/FREE Full Text
35. 35.↵
    1. Maia AC Jr.,
    2. Malheiros SM,
    3. da Rocha AJ,
    4. et al

    . MR cerebral blood volume maps correlated with vascular endothelial growth factor expression and tumor grade in nonenhancing gliomas. AJNR Am J Neuroradiol 2005;26:777–83

    Abstract/FREE Full Text
36. 36.↵
    1. Cao Y,
    2. Nagesh V,
    3. Hamstra D,
    4. et al

    . The extent and severity of vascular leakage as evidence of tumor aggressiveness in high-grade gliomas. Cancer Res 2006;66:8912–17

    Abstract/FREE Full Text
37. 37.↵
    1. Karathanasis E,
    2. Chan L,
    3. Karumbaiah L,
    4. et al

    . Tumor vascular permeability to a nanoprobe correlates to tumor-specific expression levels of angiogenic markers. PLoS One 2009;4:e5843

    CrossRefPubMed
38. 38.↵
    1. Matsumoto S,
    2. Yasui H,
    3. Batra S,
    4. et al

    . Simultaneous imaging of tumor oxygenation and microvascular permeability using Overhauser enhanced MRI. Proc Natl Acad Sci U S A 2009;106:17898–903. Epub 2009 Oct 6

    Abstract/FREE Full Text
39. 39.↵
    1. Lev MH,
    2. Ozsunar Y,
    3. Henson JW,
    4. et al

    . Glial tumor grading and outcome prediction using dynamic spin-echo MR susceptibility mapping compared with conventional contrast-enhanced MR: confounding effect of elevated rCBV of oligodendrogliomas [corrected]. AJNR Am J Neuroradiol 2004;25:214–21

    Abstract/FREE Full Text